Breaks Categories: News

TuesdayNov 26, 2024 8:40 am

NetworkNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Highlights Giuseppe Rossi’s Pepito Cup Revival and Community Impact

Brera Holdings (NASDAQ: BREA) announced the return of The Pepito Cup, an annual soccer fan club tournament organized by Advisory Board member Giuseppe Rossi. Held on November 17, 2024, at the Waldwick Superdome in New Jersey and sponsored by the GIUSEPPE ROSSI ACADEMY, the event featured 12 teams competing in a 25-minute match elimination format, with Napoli Club NYC crowned champions. Open to the public and family-friendly, the event reflects Brera Holdings' commitment to fostering community engagement and expanding its global sports footprint through initiatives led by influential figures like Rossi. To view the full press release, visit https://nnw.fm/58wSD About…

Continue Reading

MondayNov 25, 2024 1:23 pm

NetworkNewsBreaks – BioAdaptives Inc. (BDPT) to Proceed with Human Clinical Trial for Zeranovia(TM)

BioAdaptives (OTC: BDPT) today announced its receipt of approval for a human clinical trial of its weight management product, Zeranovia(TM). Approved by an Institutional Review Board, the trial will be managed and supervised by doctors in Las Vegas, Nevada. “According to data from the National Institutes of Health's Office of Dietary Supplements (‘ODS’), less than 1.0% of nutraceuticals sold in the United States undergo examination in human clinical trials,” said BioAdaptives CEO James Keener. “We are committed to supplying the highest quality products with provable scientific results. Zeranovia’s(TM) success is based on a high-protein blend of vitamins, minerals, and five…

Continue Reading

MondayNov 25, 2024 12:05 pm

NetworkNewsBreaks – Sprout Social Inc.’s (NASDAQ: SPT) Strategic AI Investments Amid Financial Challenges

Sprout Social (NASDAQ: SPT) is a prominent player in the social media management software industry. The company focuses on providing cloud-based solutions that help brands manage their social media presence effectively. Sprout’s competitors include companies like Hootsuite and Buffer, but it distinguishes itself with its advanced AI-driven tools. Sprout Social’s recent updates to its AI solutions aim to enhance brand competitiveness and operational efficiency. Despite a negative price-to-earnings (“P/E”) ratio of -28.20, indicating current negative earnings, the company is investing in innovations like “Generate Posts” and “Smart Categories” to streamline social media operations. These tools help brands maintain their voice…

Continue Reading

MondayNov 25, 2024 11:03 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Presents Progress in Pivotal Study of Berubicin for Glioblastoma Treatment

CNS Pharmaceuticals (NASDAQ: CNSP) announced updated results from its ongoing pivotal trial evaluating Berubicin, a novel anthracycline crossing the blood-brain barrier, against Lomustine in recurrent glioblastoma multiforme (“GBM”). Presented at the 29th Annual Meeting of the Society for Neuro-Oncology, the data show balanced patient demographics and safety profiles between the study arms, with Berubicin showing comparable adverse event rates and promising potential to improve overall survival (“OS”), the trial's primary endpoint. With enrollment completed at 252 patients, CNS expects to report primary analysis data in early 2025. Berubicin holds FDA Fast Track and Orphan Drug Designations, underscoring its significance in…

Continue Reading

MondayNov 25, 2024 10:06 am

NetworkNewsBreaks – HealthLynked Corp. Completes $3 Million Cash Consideration from ACO Health Partners Sale

HealthLynked (OTCQB: HLYK) announced the receipt of $500,000 as part of its contractual share of shared savings generated by ACO Health Partners (AHP) during the 2023 performance period. This marks the final payment under the terms of the January 2023 sale of AHP, bringing the total gross proceeds to $3 million, including $750,000 from the initial sale and $1.75 million in participation-based payments. CEO Dr. Michael Dent highlighted the strategic value of the sale, enabling HealthLynked to focus on advancing its core healthcare technology and patient engagement solutions. To view the full press release, visit https://nnw.fm/lyC0f About HealthLynked Corp. HealthLynked…

Continue Reading

MondayNov 25, 2024 8:25 am

NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Share Clinical and Strategic Updates

Annovis Bio (NYSE: ANVS), a clinical-stage company developing therapies for neurodegenerative diseases, will host a live investor webcast on Dec. 11, 2024, at 4:30 PM EST. Led by Founder and CEO Dr. Maria Maccecchini, the event will highlight updates on Phase 3 studies for Parkinson’s and Alzheimer’s diseases, regulatory milestones, financial strategies, and plans for advancing neurodegenerative therapies in 2025. To view the full press release, visit https://nnw.fm/qFEH9 About Annovis Bio Inc. Annovis Bio, headquartered in Malvern, Pennsylvania, is committed to addressing neurodegeneration in diseases such as Alzheimer’s and Parkinson’s. The company is developing innovative therapies that target multiple neurotoxic…

Continue Reading

MondayNov 25, 2024 8:00 am

NetworkNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Updates 2024 Exploration Progress at Storm Copper Project, Highlights New Discoveries

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) provided an update on the 2024 exploration activities at the Storm Copper Project on Somerset Island, Nunavut, operated by American West Metals Limited under a 20/80 joint venture agreement. Aston Bay retains a free carried interest until a mining decision is made following a bankable feasibility study. CEO Thomas Ullrich highlighted the discovery of two new zones with copper, zinc, and silver mineralization, emphasizing the potential of the 110 km-long trend. He noted the success of prospecting, geophysics, geochemistry, and drilling efforts and announced ongoing development of a maiden resource and further testing of…

Continue Reading

MondayNov 25, 2024 7:30 am

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Reports Strong Financial Performance and New Contracts, Expanding Footprint in US and Israel

SuperCom (NASDAQ: SPCB) reported a solid performance for Q3 2024, with year-to-date revenue reaching $21.3 million, a 2% increase over the prior year, and gross profit rising 35% to $10.7 million. Strategic contract wins, including a 5-year electronic monitoring project with Israel Prison Service and multiple U.S. contracts in states like West Virginia, Maryland, and New York, underscore SuperCom’s expanding presence in public safety and rehabilitative services. CEO Ordan Trabelsi highlighted SuperCom’s operational efficiency and growth potential, as demonstrated by improved profitability, positive free cash flow, and an increased gross profit margin. The company remains focused on innovation and deepening client…

Continue Reading

FridayNov 22, 2024 12:45 pm

NetworkNewsBreaks – IBN, BioMedWire Continue Collaboration to Amplify Reach of Dynamic Global Events’ 2025 Lineup

IBN, a leading communications organization with an extensive portfolio of over 60 brands, today announced its fifth consecutive year partnering with Dynamic Global Events (“DGE”) as an official media sponsor for 2025. BioMedWire (“BMW”), IBN’s digital platform dedicated to emerging life sciences opportunities, will also serve as a media partner, expanding DGE's event reach and visibility throughout the year. DGE serves the pharmaceutical and life sciences sectors with educational B2B events that drive industry networking, partnership opportunities and business development. “We are thrilled to extend our collaboration with IBN and BioMedWire for another year,” said DGE’s Head of Marketing, Elizabeth…

Continue Reading

FridayNov 22, 2024 11:45 am

NetworkNewsBreaks – Supreme Court Decision on Meta Platforms Inc. (NASDAQ: META) Lawsuit

The U.S. Supreme Court has opted not to rule on a securities fraud lawsuit against Meta (NASDAQ: META). The lawsuit accuses Facebook, a subsidiary of Meta, of misleading investors about the misuse of user data on its platform. This decision leaves the case unresolved, as the court has chosen to sidestep the issue rather than allowing it to proceed. Meta’s stock price currently stands at $558.10, reflecting a decrease of approximately 0.89% or $4.99. This decline may be influenced by the ongoing legal uncertainties surrounding the company. During the trading day, META’s stock has fluctuated between a low of $556.49…

Continue Reading